Your browser doesn't support javascript.
loading
Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study.
Fatima, Syeda Sadia; Jamil, Zehra; Abidi, Syed Hani; Nadeem, Daniyal; Bashir, Zara; Ansari, Ahmed.
Afiliação
  • Fatima SS; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
  • Jamil Z; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
  • Abidi SH; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
  • Nadeem D; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
  • Bashir Z; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
  • Ansari A; Syeda Sadia Fatima, Zehra Jamil, Syed Hani Abidi, Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan, Karachi 74800, Pakistan.
World J Diabetes ; 8(6): 304-310, 2017 Jun 15.
Article em En | MEDLINE | ID: mdl-28694931
AIM: To assess circulatory levels of interleukin-18 (IL-18) and determine whether the presence of IL-18 promoter polymorphism influences metabolic syndrome phenotypes. METHODS: This study recruited one hundred and eighty individuals divided into three groups with sixty subjects each as: Normal weight (18.0-22.9 kg/m2), overweight (23.0-25.9 kg/m2) and obese (> 26.0 kg/m2) according to South Asian criteria of BMI. Fasting blood glucose (FBG), Lipid profile, insulin, IL-18 and tumor necrosis factor (TNF)α were measured using ELISA kits, whereas low density lipoprotein (LDL)-cholesterol, insulin resistance (HOMA-IR) and insulin sensitivity (QUICKI) were calculated. The body fat percentage (BF) was measured through bioelectrical impedance analysis; waist and hip circumference were measured. Genotyping of IL-18 -607 C/A polymorphism was performed by using tetra-primer amplification refractory mutation system. Student t test, One-way analysis of variance, Hardy-Weinberg equilibrium, Pearson's χ2 test and Pearson's correlation were used, where a P value < 0.05 was considered significant. RESULTS: In an aged matched study, obese subjects showed higher levels of FBG, cholesterol, triglycerides and LDL levels as compared to normal weight (P < 0.001). Highest levels of IL-18 and TNF levels were also seen in obese subjects (IL-18: 58.87 ± 8.59 ng/L) (TNF: 4581.93 ± 2132.05 pg/mL). The percentage of IL-18 -607 A/A polymorphism was higher in overweight and obese subjects vs normal weight subjects (P < 0.001). Moreover, subjects with AA genotype had a higher BF, insulin resistance, TNFα and IL-18 levels when compared with subjects with AC (heterozygous) or CC (wild type) genotypes. However, we did not find any difference in the lipid profile between three subgroups. CONCLUSION: This preliminary data suggests that IL-18 polymorphism affects IL-18 levels that might cause low grade inflammation, further exacerbated by increased TNFα. All these increase the susceptibility to develop MetS. Further studies are required to validate our findings.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Diabetes Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Paquistão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Diabetes Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Paquistão País de publicação: Estados Unidos